CalciMedica is trading 6.32% lower at $1.63, down from its September 24 close of $1.74; no company-specific catalyst for the September 25 decline was identified.
- Major indices were reported higher while CalciMedica fell.
- No new company announcement, earnings release, analyst action or regulatory catalyst was identified. The latest company news found was its September 8 conference participation announcement.
- Nasdaq compliance and financing developments had been disclosed previously and were not new on September 25.